Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-5...
-
EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue 39% Full-Year YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in the Number of...
-
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
-
American Shared Hospital Services Announces Fourth Quarter and Full Year Financial Results Conference Call
-
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
-
FREMONT, Calif., March 22, 2026 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today...
-
T. Rowe Price CEO Robert Sharps joins Longeviti Neuro Solutions board, signaling growth as the company scales its AI-enabled neurotechnology platform.
-
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan
-
CARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
-
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts